Lovastatin; Niacin Patent Expiration
Lovastatin; Niacin is Used for treating hyperlipidemia and hypercholesterolemia by dosing once a day in the evening or at night, with the potential need for flush inhibiting agents like aspirin. It was first introduced by Abbvie Inc
Lovastatin; Niacin Patents
Given below is the list of patents protecting Lovastatin; Niacin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Advicor | US6469035 | Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
Mar 15, 2018
(Expired) | Abbvie |
| Advicor | US6080428 | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
May 27, 2017
(Expired) | Abbvie |
| Advicor | US6129930 | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US6406715 | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique urinary metabolite profiles |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US6676967 | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US6746691 | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US6818229 | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US7011848 | Hydrophobic component free sustained release nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
Sep 20, 2013
(Expired) | Abbvie |
| Advicor | US7998506 | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
Sep 20, 2013
(Expired) | Abbvie |
Lovastatin; Niacin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List